SINGAPORE (April 25): DBS is maintaining its “hold” recommendation and target price of $2.09 on IHH Healthcare Berhad (IHH) despite its announcement that 60%-owned subsidiary, Acibadem, has signed agreements to acquire Bulgaria-based hospital Tokuda Hospital Sofia and to merge with City Clinic.

Have a premium account? Sign in to continue reading.

Unlimited access to all stories from $4.99/month*

The latest reporting and analysis from business and investments to news and views on social issues.


  • Simultaneous logins across all devices
  • Instant access to past digital issues
  • Unlimited access to The Edge Malaysia
  • *For annual subscription plan only. T&Cs apply